Medicare Enrolled
Dr. Daniel Zuckerbrod, M.D.
Ophthalmology · Detroit, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zuckerbrod from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zuckerbrod?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zuckerbrod
Dr. Daniel Zuckerbrod is an ophthalmology specialist in Detroit, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Zuckerbrod performed 4,389 Medicare services across 3,221 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zuckerbrod received a total of $15,764 from 38 pharmaceutical and/or device companies across 629 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zuckerbrod is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 14% volume in MI
$15,764 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,389
Medicare services
Top 14% in MI for ophthalmology
3,221
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~219 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
728 | $66 | $110 |
| Microfluid analysis of tears A laboratory test that analyzes tear fluid using microfluidic technology to measure specific biomarkers. This procedure helps evaluate the composition of tears for diagnostic purposes. |
526 | $22 | $50 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
463 | $87 | $145 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
380 | $25 | $200 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
360 | $43 | $180 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
248 | $26 | $150 |
| Eye drainage system examination An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye. |
227 | $21 | $55 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
204 | $30 | $150 |
| Retinal and optic nerve function test A diagnostic test that measures how well the retina and optic nerve are functioning. |
135 | $97 | $250 |
| Dark adaptation test This test evaluates how well your eyes adjust to changes in light and dark conditions. It includes an interpretation of the results and a formal report. |
115 | $32 | $125 |
| Imaging of front third of eye Imaging of the front third of the eye. |
109 | $22 | $150 |
| Ultrasound of eye using water bath method An ultrasound imaging test of the eye that uses a water bath technique to visualize internal eye structures. |
105 | $104 | $300 |
| Aflibercept eye injection (Eylea) | 94 | $690 | $2,100 |
| Slit lamp examination of the eye This procedure uses a specialized microscope to examine the front portion of the eye. |
91 | $27 | $200 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
81 | $104 | $250 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
75 | $93 | $600 |
| Ultrasound scan to determine eye length and lens power An ultrasound procedure used to measure the length of the eye and calculate the power of the lens. |
67 | $45 | $200 |
| Multiple eye pressure measurements over time This procedure involves taking several measurements of the fluid pressure inside the eye across an extended period. It is used to monitor intraocular pressure levels. |
63 | $51 | $125 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
47 | $261 | $1,000 |
| Cataract surgery with lens implant Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision. |
38 | $430 | $1,500 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
38 | $32 | $200 |
| Tear duct plug insertion A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface. |
29 | $88 | $300 |
| Retinal laser treatment for leaking blood vessels This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels. |
27 | $269 | $1,500 |
| Dilation of eye fluid drainage A procedure to widen the drainage pathways in the eye to help fluid flow out more easily. |
26 | $263 | $2,500 |
| Retinal laser destruction of growth A laser procedure used to destroy abnormal growths in the retina. |
25 | $406 | $1,100 |
| Ultrasound scan of cornea to determine thickness An ultrasound procedure used to measure the thickness of the cornea. |
25 | $7 | $100 |
| Visual field test, intermediate A test that measures your side vision to check for blind spots or other vision changes. |
23 | $33 | $125 |
| Cataract removal with lens implant and laser treatment This procedure involves removing the clouded natural lens of the eye and replacing it with an artificial prosthetic lens. It also includes laser treatment to reduce fluid production within the eye. |
21 | $528 | $3,500 |
| Laser repair to improve eye fluid flow A laser procedure used to enhance the drainage of fluid within the eye. |
19 | $191 | $900 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
21.1% medium
78.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,764
Total received (2018-2024)
Avg $2,252/year across 7 years
Top 6% in MI for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
629
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,764 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,139
2023
$2,155
2022
$3,894
2021
$3,372
2020
$1,187
2019
$1,038
2018
$1,979
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$516
Alimera Sciences, Inc.
$360
Tarsus Pharmaceuticals, Inc.
$228
ABBVIE INC.
$214
Bausch & Lomb Americas Inc.
$163
Sight Sciences, Inc.
$137
Regeneron Healthcare Solutions, Inc.
$133
Apellis Pharmaceuticals, Inc.
$95
BIOTISSUE HOLDINGS INC.
$75
Oyster Point Pharma, Inc.
$63
LKC Technologies, Inc.
$36
Glaukos Corporation
$35
Genentech USA, Inc.
$25
Alcon Vision LLC
$21
Mallinckrodt Hospital Products Inc.
$18
Dompe US, Inc.
$14
NEW WORLD MEDICAL,INC.
$9
Top 3 companies account for 51.6% of 2024 payments
All-time payments by company (2018-2024) ›
Alimera Sciences, Inc.
$4,210
Regeneron Healthcare Solutions, Inc.
$1,322
Allergan, Inc.
$1,239
Alcon Vision LLC
$960
Aerie Pharmaceuticals, Inc.
$952
Novartis Pharmaceuticals Corporation
$743
Shire North American Group Inc
$708
Bausch & Lomb Americas Inc.
$674
ABBVIE INC.
$547
Sight Sciences, Inc.
$523
Amgen Inc.
$516
Allergan Inc.
$459
Oyster Point Pharma, Inc.
$310
Eyevance Pharmaceuticals LLC
$262
Apellis Pharmaceuticals, Inc.
$253
Kala Pharmaceuticals, Inc.
$250
Bausch & Lomb, a division of Bausch Health US, LLC
$240
AbbVie Inc.
$240
Tarsus Pharmaceuticals, Inc.
$228
Sun Pharmaceutical Industries Inc.
$188
Alcon Laboratories Inc
$168
GLAUKOS CORPORATION
$112
Glaukos Corporation
$106
Genentech USA, Inc.
$80
Ivantis, Inc
$76
BIOTISSUE HOLDINGS INC.
$75
MacuLogix, Inc.
$55
NEW WORLD MEDICAL,INC.
$53
LKC Technologies, Inc.
$36
EYEVANCE PHARMACEUTICALS LLC
$35
Rayner Intraocular Lenses Limited
$30
TearLab Corp
$22
Carl Zeiss Meditec AG
$19
Mallinckrodt Hospital Products Inc.
$18
Johnson & Johnson Surgical Vision, Inc.
$15
Dompe US, Inc.
$14
EyePoint Pharmaceuticals US, Inc.
$13
Iridex Corporation
$13
Top 3 companies account for 43.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVEFOCUS · ALPHAGAN P · AcrySof IQ PanOptix · AcrySof IQ VIVITY IOL · AdaptDx · Ahmed Glaucoma Valve · COMBIGAN · Cequa · Clareon · DEXYCU · DUREZOL · DURYSTA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · EYSUVIS · Flarex · HYDRUS Microstent · Hydrus Microstent · IACCESS · ILUVIEN · INVELTYS · Kahook Dual Blade · LOTEMAX · LOTEMAX GEL · LOTEMAX SM · LUMIGAN · LenSx · MIEBO · None Specified · OMNI SURGICAL SYSTEM · OMNI(R) SURGICAL SYSTEM (US) · OXERVATE · OZURDEX · Omidria · PAZEO · PROLENSA · PanOptix · RESTASIS · RESTASIS MULTIDOSE · ReSTOR · Rhopressa · Rocklatan · SIMBRINZA · Simbrinza · Syfovre · Systane Complete · TEARCARE SYSTEM · TEPEZZA · TRAVATAN Z · TYRVAYA · TearLab Osmolarity System · Tecnis IOL · TobraDex ST · Tobradex ST · VABYSMO · VUITY · VYZULTA · Vabysmo · Wavelight · XDEMVY · XEN · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · XIPERE · YUTIQ · ZYLET · iStent Trabecular Micro-Bypass System Model iS3 · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for ophthalmology in MI.
Geographic Context
Ophthalmologists within 10 mi
357
Per 100K population
20.1
County median income
$59,521
Nearest hospital
SINAI-GRACE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Zuckerbrod is a clinical cardiology specialist, with above-average Medicare volume (top 14% in MI), with low-engagement industry engagement in the top 6% of MI peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Zuckerbrod experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Zuckerbrod performed 728 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zuckerbrod receive payments from pharmaceutical companies?
Yes. Dr. Zuckerbrod received a total of $15,764 from 38 companies across 629 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zuckerbrod's costs compare to other ophthalmologists in Detroit?
Dr. Zuckerbrod's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zuckerbrod) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Detroit
Browse ophthalmologists in Detroit ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in MI
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in MI
Which MI ophthalmologists receive the most from drug and device companies.
By company
Alimera Sciences, Inc. Payments to Doctors
See all physicians who received payments from Alimera Sciences, Inc.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology